1-4 of 4
epstein-barr virus infections
Close
Sort by
Journal Articles

Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection

Mayumi Yoshimori, Haruna Shibayama, Ken-Ichi Imadome, Fuyuko Kawano, Ayaka Ohashi, Miwako Nishio, Norio Shimizu, Morito Kurata, Shigeyoshi Fujiwara, Ayako Arai
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1805–1815.
https://doi.org/10.1182/bloodadvances.2020002417
Published: 2021
Includes: Supplemental data
Journal Articles

Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

Clinical Trials & Observations
Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2918–2926.
https://doi.org/10.1182/bloodadvances.2020001451
Published: 2020
Includes: Supplemental data
Journal Articles

Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile

Cornelia Gujer, Anita Murer, Anne Müller, Danusia Vanoaica, Kathrin Sutter, Emilie Jacque, Nathalie Fournier, Jens Kalchschmidt, Andrea Zbinden, Riccarda Capaul, Andrzej Dzionek, Philippe Mondon, Ulf Dittmer, Christian Münz
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1129–1144.
https://doi.org/10.1182/bloodadvances.2018025536
Published: 2019
Includes: Supplemental data
Journal Articles

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

Reid W. Merryman, Philippe Armand, Kyle T. Wright, Scott J. Rodig
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2643–2654.
https://doi.org/10.1182/bloodadvances.2017012534
Published: 2017